Wegovy is licensed for chronic weight management and uses a higher target dose of 2.4mg weekly
They provide fibre, vitamins, and antioxidants that support overall health and may help to manage inflammation
The human evidence is still developing
GLP-1 Agonist plus IL-17 Inhibition in Obese Psoriatic Arthritis Save Lilly announced the topline results from its phase 3b "TOGETHER PsA" trial, showing that the combination use of ixekizumab (Taltz) and tirzepatide (Zepbound) was superior to IXE alone, yielding both significant weight loss and ACR50 disease control in adults with active psoriatic arthritis (PsA)
After six weeks, the cheeks were also lifted and the crows feet wrinkles were smoothed out (surface -11% up to -75%)
To show our appreciation, were offering 15% off all products and services for: Your dedication, service, and commitment inspire usand this is our way of giving back to you